rs5961397

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181332.3(NLGN4X):​c.625+24855T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.279 in 111,077 control chromosomes in the GnomAD database, including 3,827 homozygotes. There are 9,004 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 3827 hom., 9004 hem., cov: 23)

Consequence

NLGN4X
NM_181332.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.61

Publications

5 publications found
Variant links:
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
NLGN4X Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, X-linked 2
    Inheritance: XL Classification: STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_181332.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181332.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN4X
NM_181332.3
MANE Select
c.625+24855T>C
intron
N/ANP_851849.1Q8N0W4-1
NLGN4X
NM_001282145.2
c.625+24855T>C
intron
N/ANP_001269074.1Q8N0W4-1
NLGN4X
NM_001282146.2
c.625+24855T>C
intron
N/ANP_001269075.1Q8N0W4-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN4X
ENST00000381095.8
TSL:1 MANE Select
c.625+24855T>C
intron
N/AENSP00000370485.3Q8N0W4-1
NLGN4X
ENST00000538097.6
TSL:1
c.685+24855T>C
intron
N/AENSP00000439203.3Q8N0W4-2
NLGN4X
ENST00000275857.10
TSL:1
c.625+24855T>C
intron
N/AENSP00000275857.6Q8N0W4-1

Frequencies

GnomAD3 genomes
AF:
0.279
AC:
30953
AN:
111021
Hom.:
3819
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.487
Gnomad AMI
AF:
0.178
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.176
Gnomad EAS
AF:
0.265
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.165
Gnomad MID
AF:
0.183
Gnomad NFE
AF:
0.191
Gnomad OTH
AF:
0.292
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.279
AC:
31005
AN:
111077
Hom.:
3827
Cov.:
23
AF XY:
0.270
AC XY:
9004
AN XY:
33319
show subpopulations
African (AFR)
AF:
0.488
AC:
14872
AN:
30481
American (AMR)
AF:
0.237
AC:
2481
AN:
10482
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
464
AN:
2638
East Asian (EAS)
AF:
0.266
AC:
925
AN:
3482
South Asian (SAS)
AF:
0.201
AC:
533
AN:
2648
European-Finnish (FIN)
AF:
0.165
AC:
988
AN:
5978
Middle Eastern (MID)
AF:
0.187
AC:
40
AN:
214
European-Non Finnish (NFE)
AF:
0.191
AC:
10139
AN:
52970
Other (OTH)
AF:
0.293
AC:
444
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
759
1518
2276
3035
3794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.230
Hom.:
1696
Bravo
AF:
0.296

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.22
DANN
Benign
0.49
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5961397;
hg19: chrX-5922466;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.